January 7, 2025
Alliance Healthcare UK appoints sales director
Alliance Healthcare UK has appointed Paula Sutherland to the position of Sales Director where she will lead sales teams in…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
January 7, 2025
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering
Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) — Zhengye Biotechnology Holding Limited (the “Company” or “Zhengye”), a veterinary vaccine manufacturer…
January 7, 2025
Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
AUSTIN, TX and DURHAM, NC, Jan. 06, 2025 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company…
January 7, 2025
Umoja Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that…
January 7, 2025
Travere Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president…
January 7, 2025
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) (the “Company” or “Aclaris”), a clinical-stage biopharmaceutical…
January 7, 2025
Kura Oncology Announces Senior Executive Promotions
– Mollie Leoni, M.D. promoted to Chief Medical Officer – – Francis Burrows, Ph.D. promoted to Chief Scientific Officer –…
January 7, 2025
Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases
Novel programs will combine validated cell-targeted LNP (ctLNP) delivery with siRNA to selectively modulate T cells in vivoPrograms to focus…
January 7, 2025
Denali Therapeutics Announces Topline Results for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not…
January 7, 2025
ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical…